RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply

Chemotherapy for non‐small cell lung cancer (NSCLC) is far from satisfactory, mainly due to poor targeting of antitumor drugs and self‐adaptations of the tumors. Angiogenesis, vasculogenic mimicry (VM) channels, migration, and invasion are the main ways for tumors to obtain nutrition. Herein, RPV‐mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Liang, Cai, Fu‐yi, Yao, Xue‐min, Jing, Ming, Fu, Min, Liu, Jing‐jing, He, Si‐yu, Zhang, Lu, Liu, Xin‐ze, Ju, Rui‐jun, Li, Xue‐tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004549/
https://www.ncbi.nlm.nih.gov/pubmed/31777993
http://dx.doi.org/10.1111/cas.14256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004549/
https://www.ncbi.nlm.nih.gov/pubmed/31777993
http://dx.doi.org/10.1111/cas.14256

Ejemplares similares